CTRI/2018/09/015830尚未招募未知
To evaluate Efficacy and Safety of Hydroxy chloroquinine in patients of symptomatic Oral Lichen Planus.
Dr RPGMC Kangra At Tanda0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 All Patients Except Exclusion Criteria
排除标准
- •1Age < 18 years
- •2Asymptomatic oral lesions
- •3pregnant or lactating women
- •4Use of lichenoid reaction inducing drugs.
- •5the presence of amalgam filling close to lesions
- •6 presence of skin ,genital or other extra oral lesions
- •7Chronic liver disease, hematological disease and immune system dysfunction
- •8Any other absolute/relative contraindications of use of hydroxyl chloroquine.
研究者
相似试验
招募中
1 期
Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19COVID-19.COVID-19U07.1IRCT20150808023559N20Ardabil University of Medical Sciences100
已完成
3 期
Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19IRCT20200318046812N1Iran University of Medical Sciences324
招募中
2 期
Combination therapy in COVID 19COVID-19 pneumonia.IRCT20100228003449N30Tehran University of Medical Sciences50
招募中
3 期
Treatment of Hydroxychloroquine in Type 2 Diabetes Patients Uncontrolled on Metformin MonotherapyCTRI/2021/11/037750Ipca Laboratories Ltd
招募中
3 期
Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxisCOVID-19 pneumonia.COVID-19, virus not identifiedU07.2IRCT20130917014693N10Shahid Beheshti University of Medical Sciences100